Chapter 26 Targeted Therapy, Drug Resistance, Compound and Genetic Screens

26.1 Hallmarks of cancer

26.2 Chemo vs targeted therapy

26.3 Drug resistance

26.4 Synthetic lethality

26.5 Precision medicine

26.6 Tumor (bulk vs scRNA-seq), mice, cell lines

26.7 Compound screens

26.8 Genetic screens

26.9 Tumor heterogeneity